The power of "principles" in a national pharmaceuticals strategy

Healthcare Policy

Volumn 4, Issue 3, 2009, Pages 25-36

  Macpherson, Catherine S ^a   Kenny, Nuala P ^b  

^a Annapolis Valley Health Authority   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG MARKETING; ETHICS; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; NOTE;

EID: 67650556325     PISSN: None     EISSN: 17156572     Source Type: Journal    
DOI: 10.12927/hcpol.2009.20533     Document Type: Note

References (29)

1. Anis, A.H., D.P. Guh, D. Lacaille, C.A. Marra, A.A. Rashidi, X. Li and J.M. Esdaile. 2005. "When Patients Have to Pay a Share of Drug Costs: Effects on Frequency of Physician Visits, Hospital Admissions and Filling of Prescriptions." Canadian Medical Association Journal 173(11): 1335-1340 (Pubitemid 41713056)
2. Bayer, R., A. Caplan and N. Daniels, eds. 1983. In Search of Equity: Health Needs and the Health Care System. New York: Plenum Press.
3. Beauchamp, T. and J. Childress. 2001. Principles of Biomedical Ethics (5th ed.). Oxford, UK: Oxford University Press.
4. Canadian Health Coalition (CHC). 2006. "More for Less: A National Pharmacare Strategy." Retrieved December 12, 2008. 〈http://www. healthcoalition.ca/moreforless.pdf〉.
5. Canadian Institute for Health Information (CIHI). 2007. National Health Expenditure Trends, 1975-2006. Ottawa: Author.
6. Coalition for a Canadian Pharmaceuticals Strategy (CCPS). 2006. "Framework for a Canadian Pharmaceuticals Strategy." Retrieved September 22, 2007. 〈http://www.cha.ca/documents/ Framework%20Strategy-e. pdf〉.
7. Daniels, N. 1994. "The Articulation of Values and Principles Involved in Health Care Reform." Journal of Medicine and Philosophy 19: 425-433
8. Danis, M., C. Clancy and L.R. Churchill. 2002. Ethical Dimensions of Health Policy. New York: Oxford University Press.
9. Demers, V., M. Melo, C. Jackevisius, J. Cox, D. Kalavrouziotis, S. Rinfret, K.H. Humphries, H. Johansen, J.V. Tu and L. Pilote. 2008. "Comparison of Provincial Prescription Drug Plans and the Impact on Patients' Annual Drug Expenditures." Canadian Medical Association Journal 178(4): 405-409 (Pubitemid 351303282)
10. Dhalla, I. and A. Laupacis. 2008. "Moving from Opacity to Transparency in Pharmaceutical Policy." Canadian Medical Association Journal 178(4): 428-431 (Pubitemid 351303286)
11. Federal/Provincial/Territorial Ministerial Task Force. 2006. National Pharmaceuticals Strategy: Progress Report. Retrieved December 12, 2008. 〈http://www.councilofthefederation.ca/pdfs/npsreport-web.pdf〉.
12. First Ministers Meeting on the Future of Health Care. 2004. A 10-Year Plan to Strengthen Health Care. Retrieved December 12, 2008. 〈http://www.hc-sc.gc.ca/hcs-sss/delivery-prestation/fptcollab/2004-fmm-rpm/ index-e.html〉.
13. Fischer, F. and J. Forester. 1987. Confronting Values in Policy Analysis: The Politics of Criteria. London, UK: Sage Publications.
14. Giacomini, M., J. Hurley, I. Gold, P. Smith and J. Abelson. 2004. "The Policy Analysis of 'Values Talk': Lessons from Canadian Health Reform." Health Policy 67(1): 15-24. (Pubitemid 38058756)
15. Giacomini, M., N. Kenny and D. Dejean. 2009. "Ethics Frameworks in Canadian Health Policies: Foundation, Scaffolding or Window-Dressing?" Health Policy 89(1): 58-71. Retrieved December 12, 2008. 〈http://www. journals.elsevierhealth.com/periodicals/heap/article/PIIS0168851008001000/ abstract〉.
16. Health Charities Coalition of Canada (HCCC). 2006. "Position Statement: National Pharmaceuticals Strategy." Retrieved December 12, 2008. 〈http://www.healthcharities.ca/documents/position-statements/ National%20Pharmaceutical%20Strategy%20Position%20Statement%20- %20Approved%20Nov%2021%2006.pdf〉.
17. Health Council of Canada (HCC). 2006. Health Care Renewal in Canada: Clearing the Road for Quality. Retrieved December 12, 2008. 〈http://www. healthcouncilcanada.ca/en/index.php?option=com-content&task=view&id= 70&Itemid=72〉.
18. Health Council of Canada (HCC). 2008. A Prescription for Progress: Reviewing the National Pharmaceuticals Strategy. Toronto: Author.
19. Hoedemaekers, R. and W. Dekkers. 2003. "Key Concepts in Health Care Priority Setting." Health Care Analysis 11(4): 309-323 (Pubitemid 38112589)
20. Kenny, N.P. and M. Giacomini. 2005. "Wanted: A New Ethics Field for Health Policy Analysis." Health Care Analysis 13(4): 247-260 (Pubitemid 43016877)
21. Kenny, N.P. and C. Joffres. 2008. "Ethical Analysis of International Health Priority Setting." Health Care Analysis 16(3): 145-160 (Pubitemid 351624512)
22. Kirby, M.J.L. 2002. The Health of Canadians - The Federal Role. Final Report. Ottawa: Senate Standing Committee on Social Affairs, Science and Technology.
23. Lexchin, J. and P. Grootendorst. 2004. "Effects of Prescription Drug User Fees on Drugs and Health Services Use and on Health Status in Vulnerable Populations: A Systematic Review of the Evidence." International Journal of Health Services 34(1): 101-122 (Pubitemid 38393061)
24. National Forum on Health. 1997. Canada Health Action: Building on the Legacy. Final Report. Ottawa: Author.
25. Romanow, R. 2002. Building on Values: The Future of Health Care in Canada. Final Report. Saskatoon: Commission on the Future of Health Care in Canada. Retrieved December 17, 2008. 〈http://www.hc-sc.gc.ca/hcs-sss/alt- formats/hpb-dgps/pdf/hhr/romanow-eng.pdf〉.
26. Royal Commission on Health Services. 1964. Report of the Royal Commission on Health Services. Ottawa: Government of Canada.
27. Tamblyn, R., R. Laprise, J.A. Hanley, M. Abrahamowicz, S. Scott, N. Mayo, J. Hurley, R. Grad, E. Latimer, R. Perreault, P. McLeod, A. Huang, P. Larochelle and L. Mallet. 2001. "Adverse Events Associated with Prescription Drug Cost-Sharing among Poor and Elderly Persons." Journal of the American Medical Association 285(4): 421-429 (Pubitemid 32097260)
28. Tierney, M. and B. Manns. 2008. "Optimizing the Use of Prescription Drugs in Canada through the Common Drug Review." Canadian Medical Association Journal 178(4): 432-435 (Pubitemid 351303287)
29. Williams, R. 2006. "National Pharmaceuticals Strategy: Put the Focus on Improving Patient Outcomes." Retrieved December 12, 2008. 〈http://www.canadapharma.org/Media/News/2006/NPS-Progress-Report-092106-EN. pdf〉.